Net Loss Per Share (Tables)

3 Months Ended

Mar. 31, 2025

Earnings Per Share [Abstract]

Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share

The Company excluded the following potential common shares, presented based on amounts outstanding at period end, from the computation of diluted net loss per share attributable to common stockholders for the period indicated because including them would have had an anti-dilutive effect:

	March 31,
	2025	2024
Common stock options granted and outstanding	3,716,173	3,265,986
Warrants to purchase common stock	164,676	164,676
Restricted stock units granted and outstanding	29,740	—
ESPP shares to be purchased	6,194	—
Total	3,916,783	3,430,662